Dawn Balang
YOU?
Author Swipe
View article: Figure 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Figure 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Changes in the CD4:CD8 ratio before and after CRT. Frequency of CD4 and CD8 T-cell subsets by flow cytometry. Box plots overlay individual patient data points for CD4 frequency divided by CD8 frequency (CD4:CD8 ratio) over three longitudin…
View article: Figure 4 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Figure 4 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Correlation of the CD4:CD8 ratio with patient OS. Kaplan–Meier curves show OS probabilities by peripheral CD4:CD8 ratio for the total analyzed cohort and by HIV status. Ratios are designated as those lower than the mean (blue) vs. higher t…
View article: Supplementary Tables 1-5 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Tables 1-5 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Tables 1-5
View article: Supplementary Figure 2 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 2 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 2
View article: Data from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Data from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
The global burden of cervical cancer is highest in low- and middle-income countries. Women living with human immunodeficiency virus (HIV) infection are particularly affected by cervical cancer despite availability and adherence to antiretr…
View article: Supplementary Figure 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 1
View article: Supplementary Figure 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 1
View article: Supplementary Figure 4 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 4 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 4
View article: Table 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Table 1 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Clinical characteristics of study participants with locally advanced cervical cancer
View article: Supplementary Figure 2 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 2 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 2
View article: Figure 3 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Figure 3 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Changes in T-cell cytokine expression before and after CRT by HIV status. A, CD8 T cells and (B) CD4 T cells were stained for four primary effector/cytokine markers (CD107a, IFNγ, TNFα, and IL-2). Box plots overlay individual patient data …
View article: Supplementary Tables 1-5 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Tables 1-5 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Tables 1-5
View article: Supplementary Figure 3 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 3 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 3
View article: Supplementary Figure 4 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 4 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 4
View article: Supplementary Figure 3 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Supplementary Figure 3 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Supplementary Figure 3
View article: Figure 2 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Figure 2 from Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
Changes in T-cell subsets before and after CRT by HIV status. A, CD8 T cells and (B) CD4 T cells were stratified into four major subsets by two additional markers (CCR7 and CD45RA) to identify naïve (CD45RA+CCR7+), central memory (CD45RA−C…
View article: Cervical cancer treatment outcomes and survival in Botswana by human immunodeficiency virus status: <i>Ipabalele</i> study results
Cervical cancer treatment outcomes and survival in Botswana by human immunodeficiency virus status: <i>Ipabalele</i> study results Open
Background Cervical cancer is a leading morbidity/mortality cause, frequently co-occurring with human immunodeficiency virus (HIV) positivity, in Botswana. We examined long-term outcomes for Ipabalele study participants receiving curative …
View article: Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation
Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation Open
The global burden of cervical cancer is highest in low- and middle-income countries. Women living with human immunodeficiency virus (HIV) infection are particularly affected by cervical cancer despite availability and adherence to antiretr…
View article: Longitudinal study on quality of life following cervical cancer treatment in Botswana
Longitudinal study on quality of life following cervical cancer treatment in Botswana Open
Purpose This study longitudinally assessed the quality of life (QoL) in patients who completed chemoradiation (CRT) for cervical cancer in Botswana and compared the QoL for those living with and without HIV infection. Methods Patients with…
View article: EP047/#629 Response to treatment and overall survival of cervical cancer in women with and without HIV in Botswana: ipabalele study U54 CA190158-01
EP047/#629 Response to treatment and overall survival of cervical cancer in women with and without HIV in Botswana: ipabalele study U54 CA190158-01 Open
Objectives This study aimed to characterize factors associated with survival and response to treatment among women with cervical cancer in Botswana. Methods Patients with histologically confirmed cervical cancer were prospectively enrolled…
View article: Management of Head and Neck Cancers With or Without Comorbid <scp>HIV</scp> Infection in Botswana
Management of Head and Neck Cancers With or Without Comorbid <span>HIV</span> Infection in Botswana Open
Objectives/Hypothesis Head and neck cancer (HNC) is the fifth most common malignancy in sub‐Saharan Africa, a region with hyperendemic human immunodeficiency virus (HIV)‐infection. HIV patients have higher rates of HNC, yet the effect of H…
View article: Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana
Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana Open
Introduction The global burden of cancer continues to increase in low- and middle-income countries, particularly in sub-Saharan Africa (SSA). Botswana, a middle-income country in SSA, has the second highest prevalence of HIV worldwide and …